Clinical trials
Hematologic Neoplasms trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
140 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 2 |
| 2009 | 5 |
| 2010 | 3 |
| 2011 | 6 |
| 2012 | 6 |
| 2013 | 5 |
| 2014 | 4 |
| 2015 | 4 |
| 2016 | 9 |
| 2017 | 8 |
| 2018 | 11 |
| 2019 | 11 |
| 2020 | 9 |
| 2021 | 14 |
| 2022 | 9 |
| 2023 | 8 |
| 2024 | 8 |
| 2025 | 5 |
| 2026 | 9 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 55 |
| Recruiting | 34 |
| Unknown status | 23 |
| Active, not recruiting | 9 |
| Terminated | 9 |
| Not yet recruiting | 7 |
| Withdrawn | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 13 |
| Hospices Civils de Lyon | 7 |
| Institut Paoli-Calmettes | 6 |
| Nantes University Hospital | 5 |
| University Hospital, Clermont-Ferrand | 5 |
| Centre Hospitalier Universitaire de Nice | 4 |
| Janssen Research & Development, LLC | 4 |
| Novartis Pharmaceuticals | 4 |
| University Hospital, Caen | 4 |
| University Hospital, Toulouse | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hematologic Neoplasms | 140 |
| Neoplasms | 23 |
| Leukemia, Myeloid, Acute | 17 |
| Leukemia | 11 |
| Myelodysplastic Syndromes | 11 |
| Multiple Myeloma | 8 |
| Recurrence | 8 |
| Lymphoma | 7 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 6 |
| Graft vs Host Disease | 5 |
Trials
Showing 76 to 100 of 140. Each trial links to its page on Pharma Observatory.
40 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.